menu
The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution andidentifying potential future growth opportunities.

 

To order this 260+ page report, which features 60+ figuresand 110+ tables, please visit this link

 

Key Market Insights

§ Over 100 companies across the globe claim to providecontract fill / finish services for prefilled syringes; close to 50% of theseservice providers are large companies with over 500 employees.

§ The market landscape features the presence of well-established players in the domain, most of which claim to operate at variousscales of operation and are located in different geographies.

§ In order to acquire competencies across the supply chainand cater to the evolving needs of clients, companies offering services acrossdifferent scales of operation have established presence in various geographies.

§ Fill / finish service providers are actively investing inexpansion projects to upgrade existing capabilities and capacity; severalpartnerships, mostly focused on offering contract services, have also beenforged.

§ As expected, majority of the installed contract fill /finish capacity for prefilled syringes belongs to the large service providers,accounting for around 80% of the available global capacity.

§ The demand for fill / finish services for prefilledsyringes is likely to steadily increase in the coming years; we believestakeholders may have to expand their respective capacities to ensure aconsistent supply.

§ An evaluation of prefilled syringe combination productdevelopers revealed that Europe and North America have emerged as the keyregions for partnering opportunities for fill / finish service providers.

§ Caste Study: Around 70 prefilled syringes are beingmanufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glassand plastic materials.

§ We expect drug developers to continue to outsource theirfill / finish operations in the short to mid term, resulting in an annualizedgrowth at the rate of over 8% within the contract services market.

§ In the long-term, the projected opportunity for the fill /finish service providers for prefilled syringes is likely to be welldistributed across various types of barrel chambers, scales of operation andgeographical regions.

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

 

Table of Contents

 

1.         PREFACE
1.1.       Chapter Overview

1.2.       Scope ofthe Report

1.3.       ResearchMethodology

1.4.       ChapterOutlines

2.         EXECUTIVE SUMMARY

 

3.         INTRODUCTION

3.1.       ChapterOverview

3.2.       Introductionto Prefilled Syringes

3.2.1.    Classificationof Prefilled Syringes

3.2.2.    Manufacturingof Prefilled Syringes

3.2.3.    Advantagesof Prefilled Syringes

3.2.3.1. Benefits toHealthcare Professionals and End Users

3.2.3.2. Benefits toManufacturers

 

3.3.       Fill /Finish Processing of Prefilled Syringes

3.3.1.    StepsInvolved in Fill / Finish Process

3.3.2.    Methods ofFilling and Stoppering of Prefilled Syringes

3.3.3.    PrefilledSyringe Filling Technologies

 

3.4.       FactorsContributing to the Growth of Prefilled Syringe Fill / Finish Market

3.5.       Need forOutsourcing Fill / Finish Operations of Sterile Injectables

3.6.       Advantagesof Outsourcing Fill / Finish Services

3.7.       RisksAssociated with Outsourcing of Fill / Finish Operations

3.8.       KeyConsiderations While Selecting a Fill / Finish Service Provider

 

4.         MARKETLANDSCAPE

4.1.       ChapterOverview

4.2.       PrefilledSyringe Fill / Finish Service Providers: Overall Market Landscape

4.2.1.    Analysis byYear of Establishment

4.2.2.    Analysis byCompany Size

4.2.3.    Analysis byScale of Operation

4.2.4.    Analysis byLocation of Headquarters

4.2.5.    Analysis byLocation of Prefilled Syringe Fill / Finish Facilities

4.2.6.    Analysis byType of Drug Molecule

4.2.7.    Analysis bySyringe Barrel Material

4.2.8.    Analysis bySyringe Fill Volume

4.2.9.    Analysis byAdditional Services Offered

4.2.10.  Heat Map:Analysis by Company Size and Location of Headquarters

4.2.11.  LogoLandscape: Analysis by Company Size and Type of Drug Molecule

4.2.12.  GeographicalMap: Analysis by Scale of Operation and Location of Fill / Finish Facilities

4.2.13.  Grid Representation: Distribution by Year ofEstablishment, Company Size and Type of Drug Molecule

 

5.         PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

5.1.       ChapterOverview

5.2.       AjinomotoBio-Pharma Services

5.2.1.    Company  Overview

5.2.2.    RecentDevelopments and Future Outlook

 

5.3.       AMRI

5.3.1.    Company  Overview

5.3.2.    RecentDevelopments and Future Outlook

 

5.4.       BioPharmaSolutions

5.4.1.    Company  Overview

5.4.2.    RecentDevelopments and Future Outlook

 

5.5.       EmergentBioSolutions

5.5.1.    Company  Overview

5.5.2.    Recent Developmentsand Future Outlook

 

5.6.       Patheon(a  Thermo Fisher Scientific Company)

5.6.1.    Company  Overview

5.6.2.    RecentDevelopments and Future Outlook

 

6.         PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

6.1.       ChapterOverview

6.2.       ConsortMedical

6.2.1.    Company  Overview

6.2.2.    RecentDevelopments and Future Outlook

 

6.3.       EVER Pharma

6.3.1.    Company  Overview

6.3.2.    RecentDevelopments and Future Outlook

 

6.4.       GlaxoSmithKline

6.4.1.    Company  Overview

6.4.2.    RecentDevelopments and Future Outlook

 

6.5.       IDTBiologika

6.5.1.    Company  Overview

6.5.2.    RecentDevelopments and Future Outlook

 

6.6.       RentschlerBiopharma

6.6.1.    Company  Overview

6.6.2.    RecentDevelopments and Future Outlook

 

6.7.       Siegfried

6.7.1.    Company  Overview

6.7.2.    RecentDevelopments and Future Outlook

 

6.8.       VetterPharma

6.8.1.    Company  Overview

6.8.2.    RecentDevelopments and Future Outlook

 

7.         PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

7.1.       ChapterOverview

7.2.       Biocon

7.2.1.    Company  Overview

7.2.2.    RecentDevelopments and Future Outlook

 

7.3.       IntasPharmaceuticals

7.3.1.    Company  Overview

7.3.2.    RecentDevelopments and Future Outlook

 

7.4.       KemwellBiopharma

7.4.1.    Company  Overview

7.4.2.    Recent Developmentsand Future Outlook

 

7.5.       SquarePharmaceuticals

7.5.1.    Company  Overview

7.5.2.    RecentDevelopments and Future Outlook

 

8.         PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

8.1.       ChapterOverview

8.2.       List ofExpansions

8.2.1.    Analysis byYear of Expansion

8.2.2.    Analysis byType of Expansion

8.2.3.    Analysis byExpanded Scale of Operation

8.2.4.    Analysis byLocation of Expansion Project

8.2.5.    Analysis byType of Drug Molecule Involved

8.2.6.    Analysis byAdditional Services Offered (Expansion Specific)

 

8.3.       PartnershipModels

8.4.       List ofPartnerships and Collaborations

8.4.1.    Analysis byYear of Partnership

8.4.2.    Analysis byType of Partnership

8.4.3.    Analysis byScale of Operation (Deal Specific)

8.4.4.    Analysis byAdditional Services Offered (Deal Specific)

 

9.         CAPACITYANALYSIS

9.1.       ChapterOverview

9.2.       Assumptionsand Methodology

 

9.3.       Global,Prefilled Syringe Fill / Finish Capacity (by Number of Units)

9.3.1.    Analysis byCompany Size

9.3.2.    Analysis byScale of Operation

9.3.3.    Analysis byLocation of Headquarters

9.3.4.    Analysis byLocation of Fill / Finish Facilities

9.3.5.    Analysis byType of Drug Molecule

 

9.4.       Global,Prefilled Syringe Fill / Finish Capacity (by Volume)

9.4.1.    Analysis byCompany Size (Manufacturer)

9.4.2.    Analysis byScale of Operation

9.4.3.    Analysis byLocation of Headquarters

9.4.4.    Analysis byLocation of Fill / Finish Facilities

9.4.5.    Analysis byType of Drug Molecule

 

10.        DEMANDANALYSIS

10.1.     ChapterOverview

10.2.     Assumptionsand Methodology

 

10.3.     GlobalDemand for Prefilled Syringes Fill / Finish Services

10.3.1.  Global Demandfor Commercialized Prefilled Syringes Fill / Finish Services

10.3.1.1. Analysis by Geography

10.3.1.1.1. North America

10.3.1.1.2. Europe

10.3.1.1.3. Asia-Pacific

10.3.1.1.4. Latin America

10.3.1.1.5. Middle East and Africa

 

10.3.1.2. Analysis by Syringe Barrel Material

10.3.1.3. Analysis by Number of Barrel Chambers

10.3.1.4. Analysis by Type of Drug Molecule

10.3.1.5. Analysis by Therapeutic Area

10.3.1.6. Analysis by Specialty Syringes

 

10.3.2.  Global Demandfor Clinical Prefilled Syringes Fill / Finish Services

10.4.     Demand andSupply Analysis

10.4.1.  Demand andSupply Analysis (Scenario 1)

10.4.2.  Demand andSupply Analysis (Scenario 2)

10.4.3.  Demand andSupply Analysis (Scenario 3)

 

11.        GEOGRAPHICALASSESSMENT OF DEMAND AND SUPPLY

11.1.     ChapterOverview

11.2.     Assumptionsand Key Parameters

 

11.3.     Demand andSupply Assessment in North America

11.3.1.  KeyGeographies

11.3.1.1. US

 

11.4.     Demand andSupply Assessment in Europe

11.4.1.  KeyGeographies

11.4.1.1. France

11.4.1.2. Germany

11.4.1.3. Italy

 

11.5.     Demand andSupply Assessment in Asia-Pacific Region

11.5.1.  KeyGeographies

11.5.1.1. India

11.5.1.2. Japan

 

12.        LIKELYPARTNER ANALYSIS

12.1.     ChapterOverview

12.2.     Methodologyand Key Parameters

 

12.3.     LikelyPartner Analysis

12.3.1.  Opportunitiesin North America

12.3.1.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers

12.3.1.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers

12.3.2.  Opportunitiesin Europe

12.3.2.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers

12.3.2.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers

 

12.3.3.  Opportunitiesin Asia-Pacific and Rest of the World

12.3.3.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers

12.3.3.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers

 

13.        MARKETSIZING AND OPPORTUNITY ANALYSIS

13.1.     ChapterOverview

13.2.     ForecastMethodology and Key Assumptions

 

13.3.     OverallPrefilled Syringe Fill / Finish Services Market, 2020-2030

13.3.1.  PrefilledSyringe Fill / Finish Services Market: Distribution by Scale of Operation,2020-2030

 

13.3.2.  PrefilledSyringe Fill / Finish Services Market: Distribution by Geographical Region

13.3.2.1. Prefilled Syringe Fill / Finish Services Marketin North America

13.3.2.2. Prefilled Syringe Fill / Finish Services Marketin Europe

13.3.2.3. Prefilled Syringe Fill / Finish Services Marketin Asia-Pacific

13.3.2.4. Prefilled Syringe Fill / Finish Services MarketLatin America

13.3.2.5. Prefilled Syringe Fill / Finish Services Marketin Middle East and Africa

 

13.3.3.  PrefilledSyringe Fill / Finish Services Market: Distribution by Type of Drug Molecule,2020-2030

13.3.4.  PrefilledSyringe Fill / Finish Services Market: Distribution by Therapeutic Area

13.3.5.  PrefilledSyringe Fill / Finish Services Market: Distribution by Syringe Barrel Material,2020-2030

13.3.6.  Prefilled Syringe Fill / Finish ServicesMarket: Distribution by Number of Barrel Chambers, 2020-2030

 

14.        FUTUREGROWTH OPPORTUNITIES

14.1.     ChapterOverview

14.2.     GrowingInjectable Drugs Pipeline

14.3.     Increase inPopularity of Prefilled Syringes

14.4.     Rise inPreference for Outsourcing Fill / Finish Activities

14.5.     Advances inAseptic Fill / Finish Technologies

14.6.     GrowingOpportunities in the Asia-Pacific Region

 

15.        CASE STUDY:PREFILLED SYRINGE MANUFACTURERS

15.1.     Chapter Overview

15.2.     PrefilledSyringes: List of Available / Under Development Devices

15.2.1.  Analysis bySyringe Barrel Material

15.2.2.  Analysis byNumber of Barrel Chambers

15.2.3.  Analysis byType of Needle System

15.2.4.  Analysis byBarrel Volume

 

15.3.     PrefilledSyringes: List of Manufacturers

15.3.1.  Analysis byYear of Establishment

15.3.2.  Analysis byLocation of Headquarters

 

16.        CONCLUDINGREMARKS

16.1.     ChapterOverview

16.2.     KeyTakeaways

 

17.        INTERVIEWTRANSCRIPTS

17.1.     ChapterOverview

17.2.     Bio Elpida

17.2.1.  CompanySnapshot

17.2.2.  InterviewTranscript: Gilles Devillers, President and Cofounder

 

17.3.     IntasPharmaceuticals

17.3.1.  CompanySnapshot

17.3.2.  InterviewTranscript: Kirti Maheshwari, Chief Technical Officer

 

17.4.     IDTBiologika

17.4.1.  CompanySnapshot

17.4.2.  InterviewTranscript: Gregor Kawaletz, Chief Commercial Officer

 

17.5.     Takeda

17.5.1.  CompanySnapshot

17.5.2.  Interview Transcript: Michael Dekner,Associate Director, Head of Process Sciences Formulation and Fill / Finish

 

17.6.     Synegene

17.6.1.  CompanySnapshot

17.6.2.  Interview Transcript: Purushottam Singnurkar,Research Director and Head of Formulation Development

 

17.7.     IDEO

17.7.1.  CompanySnapshot

17.7.2.  InterviewTranscript: Jesse Fourt, Design Director

 

18.        APPENDIX 1:TABULATED DATA

 

19.        APPENDIX 2:LIST OF COMPANIES

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com